Kidney Cancer Weekly

October 20, 2025

Videos

Peer-to-Peer Clinical Conversations

ODYSSEY Study Reveals Real-World Quality of Life in Metastatic Kidney Cancer Patients - Michael Harrison & Benjamin Maughan

Benjamin Maughan

Tian Zhang speaks with Benjamin Maughan and Michael Harrison about the ODYSSEY study, examining real-world quality of life in metastatic renal cell carcinoma patients.

View

CheckMate 214 Final Overall Survival Data: Long-Term Survival Benefits of Ipi/Nivo in Kidney Cancer - Michael Serzan

Pedro Barata is joined by Michael Serzan to discuss the final overall survival data from CheckMate 214.

View

Beyond the Abstracts

Circulating Kidney Injury Molecule-1 (KIM-1) and Association with Outcome to Adjuvant Immunotherapy in Renal Cell Carcinoma- Beyond the Abstract

Lipid Metabolism of Clear Cell Renal Cell Carcinoma Predicts Survival and Affects Intratumoral CD8 T Cells - Beyond the Abstract

Conference Coverage

ESMO 2025: Bringing Any Clarity into the Non-Clear or Making Things Even Darker?

ESMO 2025: The Intratumor Mycobiome Promotes Clear Cell Renal Cell Carcinoma Progression via Neutrophil-Mediated Immune Suppression

ESMO 2025: Soluble MAdCAM-1 Predicts Outcomes in Patients with Metastatic Renal Cell Carcinoma: Results from Three Independent Clinical Trials

ESMO 2025: Discussant: Lymphocyte Activation Gene-3 (LAG3) Expression Patterns, Kidney Injury Molecule-1 (KIM-1) Levels, and Biomarkers of Response to First-Line Nivolumab plus Ipilimumab Therapy

ESMO 2025: Relevance of the CPS Score and Tumor Nephrectomy in the SUNNIFORECAST Trial Comparing Ipilimumab/nivolumab Versus Standard of Care in Non-Clear Cell Renal Cell Cancer

Articles

Editor Selected Abstracts and Commentaries

Renal Cancer

Postimmunotherapy and Vascular Endothelial Growth Factor Inhibitor Landscape in Advanced Renal Cell Carcinoma: Treatment Patterns, Costs, and Outcomes.

Real-world outcomes of immune checkpoint inhibitor-based combination therapy in older adult patients with metastatic renal cell carcinoma: a multi-center, retrospective analysis.

Same day discharge after robot assisted partial nephrectomy.

Circulating Kidney Injury Molecule-1 (KIM-1) and Association with Outcome to Adjuvant Immunotherapy in Renal Cell Carcinoma- Beyond the Abstract

Lipid Metabolism of Clear Cell Renal Cell Carcinoma Predicts Survival and Affects Intratumoral CD8 T Cells - Beyond the Abstract

Postoperative mortality in renal cell carcinoma with vena cava thrombus in the elderly population (uroCCR study n°192).

A Prognostic Risk Signature Based on Myeloid-Derived Suppressor Cells and Regulatory T Cells in Clear Cell Renal Cell Carcinoma.

Case Report: En bloc resection of inferior vena cava and renal cell carcinoma with level IV tumor thrombus associated with tumor thrombus embolization to the pulmonary arteries: presence of blood vessels inside the tumor thrombus.

SNMMI/EANM/ACNM Procedure Standard/Procedure Guideline on the Use of Molecular Imaging for Renal Mass Characterization.

HIF-2-dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear Cell Renal Cell Carcinoma.

Outcomes of Cystic Versus Solid Renal Masses After Surgery: A Prospective Single-centre Comparative Cohort Study.

Racial differences in kidney cancer histology and outcome: A nationwide study from the UroCCR Cohort.

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Kidney Cancer Weekly

Renal Cancer

Login